Compile Data Set for Download or QSAR
Report error Found 22 Enz. Inhib. hit(s) with all data for entry = 9440
TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM466529(2-{[5-Acetyl-1-(2-chlorophenyl)-1H-1,2,4-triazol-3...)
Affinity DataIC50: 0.5nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM466533(US10800746, Example WO 2011/104322 56)
Affinity DataIC50: 1.30nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM466527(2-{[5-Acetyl-1-(3-chlorophenyl)-1H-1,2,4-triazol-3...)
Affinity DataIC50: 2.30nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM466531(5-(4-Chlorophenyl)-2-({1-(3-chlorophenyl)-5-[(1S,R...)
Affinity DataIC50: 2.80nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM192468(US9187466, 110 | US9687476, 110 | US10800746, Exam...)
Affinity DataIC50: 4.30nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM466529(2-{[5-Acetyl-1-(2-chlorophenyl)-1H-1,2,4-triazol-3...)
Affinity DataIC50: 4.90nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM192455(US9187466, 68 | US9687476, 68 | US10800746, Exampl...)
Affinity DataIC50: 6nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM466528(2-{[5-Acetyl-1-(3-fluorophenyl)-1H-1,2,4-triazol-3...)
Affinity DataIC50: 6.20nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM466533(US10800746, Example WO 2011/104322 56)
Affinity DataIC50: 6.70nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM466528(2-{[5-Acetyl-1-(3-fluorophenyl)-1H-1,2,4-triazol-3...)
Affinity DataIC50: 7.5nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM466530(2-{[5-Acetyl-1-(3-chlorophenyl)-1H-1,2,4-triazol-3...)
Affinity DataIC50: 7.70nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM192455(US9187466, 68 | US9687476, 68 | US10800746, Exampl...)
Affinity DataIC50: 8.30nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM192468(US9187466, 110 | US9687476, 110 | US10800746, Exam...)
Affinity DataIC50: 15.2nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM192453(US9187466, 54 | US9687476, 54 | US10800746, Exampl...)
Affinity DataIC50: 16.6nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM192467(US9187466, 101 | US9687476, 101 | US10800746, Exam...)
Affinity DataIC50: 23.8nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM192454(US9187466, 60 | US9687476, 60 | US10800746, Exampl...)
Affinity DataIC50: 32.6nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM466527(2-{[5-Acetyl-1-(3-chlorophenyl)-1H-1,2,4-triazol-3...)
Affinity DataIC50: 34.5nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM192467(US9187466, 101 | US9687476, 101 | US10800746, Exam...)
Affinity DataIC50: 42.2nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM192454(US9187466, 60 | US9687476, 60 | US10800746, Exampl...)
Affinity DataIC50: 54.2nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM466531(5-(4-Chlorophenyl)-2-({1-(3-chlorophenyl)-5-[(1S,R...)
Affinity DataIC50: 55nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM192453(US9187466, 54 | US9687476, 54 | US10800746, Exampl...)
Affinity DataIC50: 56.4nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM466530(2-{[5-Acetyl-1-(3-chlorophenyl)-1H-1,2,4-triazol-3...)
Affinity DataIC50: 123nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent